%0 Journal Article
%T      Antiplatelet Therapy and Kidney Function in Non-Dialysis Chronic Kidney Disease: A Two-Centre Observational Study in Nigeria
%A Peter K. Uduagbamen
%A Titilope A. Bamikefa
%A Adesola T. Oyelese
%A Shitu Abdul-Karim O
%A Gbemi H. Ano-Edward
%A Adeola A. Adeleke
%A Oseiga P Odafen
%A David O. Siden
%A Oluwadamilola E. Tijani
%A Divine-Michael Iwuh
%A Princess T. Adebanwi
%J International Journal of Pharmaceutical Research and Allied Sciences
%@ 2277-3657
%D 2024
%V 13
%N 2
%R 10.51847/EbWPUU4ekG
%P 86-96
%X Antiplatelet therapy used in preventing cardiovascular events in chronic kidney disease may be associated with higher risks of bleeding, low efficacy from fewer occlusive atherosclerotic disease), attenuation of the inflammatory process, and changes in the haemogram. We prospectively determined the kidney function, the haemogram, and the lipid profile of participants with and without antiplatelet therapy. The population with a mean age of 69.21 ± 11.73 years, had more women (65.88%), p=0.001. Participants' age was positively correlated with the CKD stage, p
%U https://ijpras.com/article/nbsp-antiplatelet-therapy-and-kidney-function-in-non-dialysis-chronic-kidney-disease-a-two-cen-uq5iw2uc3b7hm1c